GlassScriptPhysician profile
Joan Miller
NPI 1174972152
$1,582.99
in general payments reported to CMS, 2019-2025
19 companies · $76.23 in 2025
The $76.23 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $606 · 2022: $531 · 2023: $334 · 2024: $36.31 · 2025: $76.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $419.62 | 2021-2023 | |
| Supernus Pharmaceuticals, INC. | $163.33 | 2021-2022 | |
| Kaleo, INC. | $132.56 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $122.55 | 2022-2023 | Jornay Pm |
| Merck Sharp & Dohme LLC | $119.46 | 2021-2024 | Vaqta, Gardasil 9, Vaxelis |
| Lilly USA, LLC | $117.47 | 2021-2023 | Mounjaro, Trulicity |
| Takeda Pharmaceuticals U.S.A., INC. | $96.80 | 2021-2022 | |
| Cranial Technologies, INC | $69.48 | 2021-2024 | Doc Band |
| Teva Pharmaceuticals USA, INC. | $60.04 | 2021 | |
| Glaxosmithkline, LLC. | $47.56 | 2021-2022 | |
| Sobi, INC | $41.75 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $40.30 | 2025 | Airsupra |
| Genentech USA, INC. | $35.16 | 2021-2022 | |
| Adlon Therapeutics L.P. | $30.14 | 2021 | |
| Astellas Pharma US INC | $22.09 | 2025 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.06 | 2021 | |
| Pfizer INC. | $16.76 | 2023 | |
| Exact Sciences Corporation | $13.84 | 2025 | The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.